Physician profile
Hugo E Benalcazar
NPI 1366480972
$380,181.69
in general payments reported to CMS, 2019-2025
15 companies · $7,974 in 2025
The $7,974 reported for 2025 was more than what 84% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $65K · 2021: $70K · 2022: $74K · 2023: $63K · 2024: $53K · 2025: $7,974.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $124K · Food and Beverage: $25.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $123,530.12 |
| Food and Beverage | $25.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $215,972.78 | 2021-2025 | Rialto Si Fusion System |
| Medtronic USA, INC. | $90,935.62 | 2019-2020 | |
| Altus Partners. LLC | $72,845.78 | 2020-2023 | Fuji Cervical Plate System |
| Integrity Implants INC. | $115.81 | 2021 | |
| Orthofix Medical, INC. | $90.92 | 2019 | |
| Ethicon US, LLC | $41.44 | 2019 | |
| Si-Bone, INC. | $34.51 | 2019 | |
| Centinel Spine, LLC | $27.31 | 2021 | |
| Sanara Medtech INC. | $25.29 | 2025 | Celleraterx |
| Tersera Therapeutics LLC | $20.97 | 2019 | |
| Kls-Martin L.P. | $16.32 | 2021 | |
| Providence Medical Technology, INC. | $15.26 | 2019 | |
| Nevro Corp. | $14.56 | 2021 | |
| Spineology INC. | $13.15 | 2020 | |
| Stryker Corporation | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hugo Benalcazar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.